BackLifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Overview

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Receivables

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's receivables is $9.9M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$9.86M
3.31% YoYΔ $-337657.00 vs prior year quarter

Peer average

Loading

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Receivables History

Loading

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A vs. peers: Receivables Comparison

Loading

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A (LFMDP) FAQ

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A (LFMDP) currently reports a receivables of $9.9M as of March 2026. That compares with $10M in the prior-year period — down 3.3% year over year. Use the charts on this page to explore LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's receivables history and peer comparisons.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's receivables decreased from $10M to $9.9M — a 3.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A reported $9.9M in receivables as of March 2026. That compares with $10M in the prior-year period — down 3.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $9.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A, and consider following LFMDP for alerts when major investors trade the stock.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is classified in the Healthcare sector. On receivables, it currently shows $9.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LFMDP with unrelated industries.